Storia in 2 fonti

Eli Lilly launches cancer drug Tanstrive in India

The launch follows marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) for patients with locally advanced or metastatic solid tumours with a rearranged during transfection (RET) gene, the company said in a statement.

Raccontata da

economictimes.indiatimes.com

thehindubusinessline.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

economictimes.indiatimes.comStai leggendo3 h fa

Eli Lilly launches cancer drug Tanstrive in India

originale

thehindubusinessline.com39 min fa

Lilly launches cancer therapy drug Tanstrive

Eli Lilly launches Tanstrive, a targeted oral cancer therapy for RET-altered tumors, priced at ₹2.15 lakh for two weeks.

Leggi questa versione → originale

Timeline cronologica

giovedì 25 giugno 2026·economictimes.indiatimes.com
Eli Lilly launches cancer drug Tanstrive in India
The launch follows marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) for patients with locally advanced or metastatic solid tumours with a…
giovedì 25 giugno 2026·thehindubusinessline.com
Lilly launches cancer therapy drug Tanstrive
Eli Lilly launches Tanstrive, a targeted oral cancer therapy for RET-altered tumors, priced at ₹2.15 lakh for two weeks.